Lv2
150 积分 2024-01-17 加入
Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (CheckPAC)
58分钟前
待确认
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
2个月前
已完结
Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers
2个月前
已完结
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
2个月前
已完结
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors
5个月前
已完结
皖公网安备34019202002308
